Home Biosciences
Home Biosciences is a European biotech venture builder leveraging an asset-centric operating model inspired by US venture-funded biotech models. It creates and scales biotech companies by assembling expert teams and dedicated entities fully financed by Home Biosciences. The company focuses on capital-efficient, agile development with multiple fully funded ventures progressing to major value inflection points. Its pipeline includes One Biosciences, a techbio company using single-cell and AI technology for cancer profiling, and Sequantrix, which develops anti-fibrotic drug candidates using large single-cell datasets. Backed by Redmile Group and Sofinnova Partners, Home Biosciences operates with a centralized executive team overseeing dedicated project teams to accelerate discovery and development addressing unmet medical needs.
Home Biosciences
Home Biosciences is a European biotech venture builder leveraging an asset-centric operating model inspired by US venture-funded biotech models. It creates and scales biotech companies by assembling expert teams and dedicated entities fully financed by Home Biosciences. The company focuses on capital-efficient, agile development with multiple fully funded ventures progressing to major value inflection points. Its pipeline includes One Biosciences, a techbio company using single-cell and AI technology for cancer profiling, and Sequantrix, which develops anti-fibrotic drug candidates using large single-cell datasets. Backed by Redmile Group and Sofinnova Partners, Home Biosciences operates with a centralized executive team overseeing dedicated project teams to accelerate discovery and development addressing unmet medical needs.